MIR22HG and Parkinson disease: In contrast, MIR17HG and MIR22HG, which have been implicated in AD and PD (Ning et al. 2022; Russo et al. 2024; Zhang et al. 2022), both show late upregulation at 168H with variable phasic expression throughout the time‐course (Figure S3D).